CLINICAL_TRIALS
trial_result
· 2016-10-11
Clinical Trial Update: Pharmacokinetics and Pharmacodynamics of Apixaban in Subjects on Hemodialysis [Phase 1]
Summary
Phase 1 pharmacokinetic and pharmacodynamic study of apixaban in adults with end-stage renal disease on hemodialysis; results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Bristol-Myers Squibb | Conditions: End Stage Renal Disease | Phase 1 | Status: COMPLETED | Results posted: 2016-10-11